Latest Posts

mASCARA team in Cardiff, proudly supporting the Every Woman Festival; a festival dedicated to woman health education, which has the aim of addressing gender health inequality which is still very real problem. Anal cancer is the prime example, with 67% … Continued

An excellent read for the Christmas break. Here is a summary of the Review published by the mASCARA team: Anal cancer rates are on the rise, especially for women. Women with a background of genital dysplasia or cancer have been … Continued

mASCARA team at ESCP in Dublin, presenting our local data on the management of anal HSIL in women. Our audit highlighted that out of 91 women with anal cancer (between 2001 and 2022) only 1 was being monitored for anal … Continued

The mASCARA team attended ACPGBI in Edinburgh. There is an ongoing need to improve research focused around the early detection and prevention of anal cancer. The importance of an International Anal Cancer Registry to drive research with the statistical power … Continued

Danni Brogden attended the IANS meeting in New York in June 2022. As well as enjoying the New York city life, she presented the study teams’ work on the treatment of early ASCC.

The results from the ANCHOR study have been published. This is the first randomised control trial to finally determine the benefit of treating anal HSIL in the prevention of anal squamous cell carcinoma in PLWH. The study showed a 57% … Continued

Danni Brogden are attending the IANS Scientific Meeting  in Amsterdam in November. The programme looks excellent, in particular the team is looking forward to the updates on the SPANC and ANCHOR trials.  The team is also looking forward to making further mASCARA … Continued

Members of the mASCARA team are attending the European Society of Coloproctology Conference later this month in Vienna where we will be presenting our work on Anal Intraepithelial Neoplasia topical and ablative treatments.   We are looking to make further collaborations … Continued